Clinical Study to Evaluate the Efficacy, Safety, and Tolerability of ACT-128800 in Patients With Relapsing-remitting Multiple Sclerosis

Clinical trial NCT01006265 · COMPLETED

Trial details

NCT number: NCT01006265
Sponsor: Actelion
Status: COMPLETED
Phase: Phase 2
Study type: INTERVENTIONAL

Multiple Sclerosis

Start date: 2009-10-01
Primary completion: 2011-06-01
Enrollment: 464

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.